ReviewCurrent cardiology reports2012
Current state of diagnosis and management of critical limb ischemia.
Review in Current cardiology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed.
- Single-Center In-Hospital and Outpatient Opioid Use for Lower Extremity Arterial Disease.Cureus · 2024Article
- Continuous peripheral nerve block for in-patients with lower limb ischemic pain.Clinics (Sao Paulo, Brazil) · 2021Article
- Gangrene, revascularization, and limb function improved with E-selectin/adeno-associated virus gene therapy.JVS-vascular science · 2021Article
- A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2020Article
- MicroRNA Profile of Patients with Chronic Limb-Threatening Ischemia.Diagnostics (Basel, Switzerland) · 2020Article
- ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model.Molecular pharmaceutics · 2018Article
- Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.Therapeutic advances in cardiovascular disease · 2018Review
- One Year Primary Patency of Infrapopliteal Angioplasty Using Drug- Eluting Balloons: Single Center Experience at King Hussein Medical Center.Journal of clinical imaging science · 2017Article
- Glyoxalase-1 Overexpression Reverses Defective Proangiogenic Function of Diabetic Adipose-Derived Stem Cells in Streptozotocin-Induced Diabetic Mice Model of Critical Limb Ischemia.Stem cells translational medicine · 2017Article
- The Effect of Charcot Neuroarthropathy on Limb Preservation in Diabetic Patients with Foot Wound and Critical Limb Ischemia after Balloon Angioplasty.Journal of diabetes research · 2017Article
- Vascular Regeneration in Ischemic Hindlimb by Adeno-Associated Virus Expressing Conditionally Silenced Vascular Endothelial Growth Factor.Journal of the American Heart Association · 2016Article
- Detailed cross-sectional study of 60 superficial femoral artery occlusions: morphological quantitative analysis can lead to a new classification.Cardiovascular diagnosis and therapy · 2014Article
- Positron emission tomography imaging of angiogenesis in a murine hindlimb ischemia model with 64Cu-labeled TRC105.Molecular pharmaceutics · 2013Article
- Treatment of infrapopliteal critical limb ischemia in 2013: the wound perfusion approach.Current cardiology reports · 2013Review
- Review
- Management of critical limb ischemia.Canadian family physician Medecin de famille canadien · 2012Article
- Endovascular reconstruction of popliteal and infrapopliteal arteries for limb salvage and wound healing in patients with critical limb ischemia - A retrospective analysis.Indian heart journalArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Critical limb ischemia represents the most severe form of peripheral arterial disease and carries with it severe morbidity and mortality risks. Because of comorbidity risks, early diagnosis and aggressive medical management make up an important part of the treatment paradigm for these individuals. However, in addition to managing these comorbid conditions, the physician caring for these individuals must be able to provide revascularization options that will improve arterial flow to the threatened extremity and assure healing of complicated wounds. Both open surgical and endovascular therapies have proven beneficial in restoring flow to severely ischemic limbs in these patients. Additionally, combinations of the above therapeutic methods have offered more available options for these patients. This article reviews care of patients with critical limb ischemia with critical assessment of options for medical and revascularization options.
Indexed as
Identifiers
22311595What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.